| Literature DB >> 30269238 |
Marianne Hollensteiner1,2, Melanie Botzenmayer3, David Fürst4, Martin Winkler5, Peter Augat6,5, Sabrina Sandriesser6,5, Falk Schrödl7, Benjamin Esterer4, Stefan Gabauer4, Klaus Püschel8, Andreas Schrempf4.
Abstract
Vertebral augmentation techniques are used to stabilize impacted vertebrae. To minimize intraoperative risks, a solid education of surgeons is desirable. Thus, to improve education of surgeons as well as patient safety, the development of a high-fidelity simulator for the surgical training of cement augmentation techniques was initiated. The integrated synthetic vertebrae should be able to provide realistic haptics during all procedural steps. Synthetic vertebrae were developed, tested and validated with reference to human vertebrae. As a further reference, commercially available vertebrae surrogates for orthopedic testing were investigated. To validate the new synthetic vertebrae, characteristic mechanical parameters for tool insertion, balloon dilation pressure and volume were analyzed. Fluoroscopy images were taken to evaluate the bone cement distribution. Based on the measurement results, one type of synthetic vertebrae was able to reflect the characteristic parameters in comparison to human vertebrae. The different tool insertion forces (19.7 ± 4.1, 13.1 ± 0.9 N, 1.5 ± 0.2 N) of the human reference were reflected by one bone surrogate (11.9 ± 9.8, 24.3 ± 3.9 N, 2.4 ± 1.0 N, respectively). The balloon dilation pressure (13.0 ± 2.4 bar), volume (2.3 ± 1.5 ml) of the synthetic vertebrae were in good accordance with the human reference (10.7 ± 3.4 bar, 3.1 ± 1.1 ml). Cement application forces were also in good accordance whereas the cement distribution couldn't be reproduced accurately. Synthetic vertebrae were developed that delivered authentic haptics during transpedicular instrument insertion, balloon tamp dilation and bone cement application. The validated vertebra model will be used within a hybrid simulator for minimally invasive spine surgery to educate and train surgeons.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30269238 PMCID: PMC6182710 DOI: 10.1007/s10856-018-6161-2
Source DB: PubMed Journal: J Mater Sci Mater Med ISSN: 0957-4530 Impact factor: 3.896
Fig. 1Schematic view a and real measurement setup b of transpedicular needle insertion. (1: material testing machine, 2: load cell, 3: adapter for Jamshidi needle, 4: Jamshidi needle, 5: specimen, 6: 3D bench vise with embedding pot)
Fig. 2Schematic view a and real measurement setup b of kyphoplasty balloon dilation measurements (1: material testing machine, 2: load cell, 3: plunger, 4: ballon expander, 5: pressure sensor, 6: balloon tamp, 7: specimen)
Fig. 3Schematic view (a) and real measurement setup (b) of vertebroplasty cement application measurements (1: material testing machine, 2: load cell, 3: syringe filled with cement, 4: specimen, 5: bone cement)
Results of needle insertion measurements in fresh frozen human vertebrae (Human), three varying customized bone surrogates (SV1, SV2, SV3) and a commercially available bone model (SB) (mean ± standard deviation (p-value in comparison to human bones))
| 32.7 ± 20.3 | 35.2 ± 32.9 (0.989) | 24.8 ± 17.6 (0.051) | 28.2 ± 24.9 (0.006*) | 26.9 ± 10.0 (0.731) | |
| 24.4 ± 20.4 | 40.2 ± 27.6 (0.136) | 28.1 ± 19.8 (0.220) | 17.9 ± 17.5 (0.021*) | 78.0 ± 24.9 (0.001*) | |
| 2.8 ± 2.0 | 3.8 ± 2.7 (0.354) | 3.1 ± 1.9 (0.495) | 1.4 ± 1.3 (<0.001*) | 1.5 ± 0.0 (0.343) |
∗p < 0.05
Fig. 4Fluoroscopy image during transpedicular needle insertions (a synthetic vertebra; b human vertebra)
Results of kyphoplasty balloon dilation measurements in fresh frozen human vertebrae (Human), two varying customized bone surrogates (SV2, SV3) (mean ± standard deviation (p-value in comparison to human bones))
| 3.1 ± 1.1 | 4.4 ± 1.4 (0.472) | 2.3 ± 1.0 (0.101) | |
| 10.7 ± 3.4 | 12.3 ± 2.1 (0.082) | 12.3 ± 2.7 (0.042*) |
∗p < 0.05
Fig. 5Fluoroscopy image during balloon dilation in an synthetic (a) and a human (b) vertebra
Results of cement application in fresh frozen human vertebrae (Human) and two varying customized bone surrogates (SV2, SV3) (mean ± standard deviation (p-value in comparison to human bone))
|
| ||||
|---|---|---|---|---|
| 1 | 15.2 ± 6.8 | 8.1 ± 4.1 (0.006*) | 9.9 ± 2.7 (0.094) | |
| 2 | 15.9 ± 5.8 | 8.8 ± 2.7 (0.003*) | 10.8 ± 1.9 (0.092) | |
| 3 | 17.0 ± 4.58 | 9.4 ± 2.7 (<0.001*) | 11.5 ± 1.4 (0.003*) | |
| 4 | 18.4 ± 4.2 | 10.2 ± 2.9 (<0.001*) | 12.3 ± 1.5 (0.001*) | |
| 5 | 19.6 ± 5.0 | 10.9 ± 2.9 (<0.001*) | 12.7 ± 1.0 (0.001*) | |
| 6 | 20.6 ± 4.3 | 11.6 ± 3.2 (<0.001*) | 13.2 ± 1.7 (0.001*) | |
| 1 | 48.9 ± 12.3 | 67.7 ± 15.5 (0.006*) | 65.2 ± 9.1 (0.013*) | |
| 2 | 41.8 ± 10.7 | 62.6 ± 13.6 (0.002*) | 64.8 ± 5.6 (0.001*) | |
| 3 | 39.7 ± 7.0 | 54.6 ± 10.0 (0.006*) | 59.4 ± 5.9 (0.001*) | |
| 4 | 39.3 ± 8.5 | 57.1 ± 7.4 (<0.001*) | 60.3 ± 7.1 (0.001*) | |
| 5 | 38.2 ± 8.6 | 56.7 ± 8.9 (0.001*) | 60.3 ± 7.6 (0.001*) | |
| 6 | 40.1 ± 10.9 | 56.7 ± 6.4 (0.001*) | 58.4 ± 7.1 (0.003*) | |
| 1 | 45.2 ± 10.3 | 44.4 ± 5.5 (0.689) | 48.2 ± 7.9 (0.123) | |
| 2 | 41.6 ± 5.5 | 47.2 ± 7.4 (0.114) | 47.1 ± 11.2 (0.180) | |
| 3 | 43.0 ± 8.4 | 47.1 ± 3.6 (0.267) | 44.7 ± 11.9 (0.689) | |
| 4 | 47.0 ± 9.9 | 54.9 ± 4.2 (0.114) | 49.2 ± 15.9 (1.000) | |
| 5 | 53.5 ± 12.0 | 66.2 ± 6.8 (0.032*) | 51.3 ± 19.7 (0.424) | |
| 6 | 59.2 ± 13.3 | 76.0 ± 8.8 (0.017*) | 57.0 ± 19.4 (0.465) |
∗p < 0.05
Fig. 6Adapted fluoroscopy images of cement applications (a human bone, b synthetic bone). After cement application, the distributed cement was colored in ascending colors (from 1 ml (light grey) to 6 ml (black))